| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.42T | 1.37T | 1.30T | 1.26T | 1.15T | 1.11T |
| Gross Profit | 241.41B | 204.71B | 188.25B | 161.58B | 184.68B | 184.75B |
| EBITDA | 95.00B | 77.66B | 71.28B | 49.38B | 78.83B | 82.73B |
| Net Income | 31.01B | 26.59B | 28.08B | 19.37B | 36.01B | 32.62B |
Balance Sheet | ||||||
| Total Assets | 1.01T | 949.27B | 958.24B | 937.15B | 909.21B | 825.40B |
| Cash, Cash Equivalents and Short-Term Investments | 63.11B | 71.56B | 65.47B | 64.99B | 85.37B | 83.83B |
| Total Debt | 237.03B | 223.90B | 214.85B | 242.06B | 211.41B | 193.75B |
| Total Liabilities | 451.19B | 412.20B | 419.04B | 434.37B | 419.66B | 381.10B |
| Stockholders Equity | 539.28B | 524.29B | 527.50B | 492.91B | 479.07B | 433.60B |
Cash Flow | ||||||
| Free Cash Flow | 58.60B | 41.47B | 38.11B | -70.93B | -11.09B | 23.12B |
| Operating Cash Flow | 90.49B | 77.44B | 86.59B | 11.33B | 33.39B | 82.52B |
| Investing Cash Flow | -41.57B | -42.72B | -39.22B | -63.68B | -23.03B | -59.31B |
| Financing Cash Flow | -71.91B | -29.85B | -53.19B | 28.42B | -11.97B | -13.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥1.09T | 13.07 | 13.07% | 1.82% | -2.06% | -3.97% | |
73 Outperform | ¥375.82B | 10.77 | 10.18% | 2.56% | 4.98% | 23.38% | |
72 Outperform | ¥479.36B | 15.17 | 9.86% | 2.58% | 0.63% | 5.96% | |
66 Neutral | ¥830.40B | 12.71 | 9.77% | 2.41% | 1.90% | 7.42% | |
63 Neutral | ¥610.55B | 15.19 | 6.04% | 2.04% | 4.68% | 16.45% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ¥275.14B | 12.27 | ― | 2.61% | 8.35% | 54.38% |